We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.45%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$520M
AUM Growth
+$3.52M
(+0.68%)
Cap. Flow
+$20.7M
Cap. Flow
% of AUM
3.98%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
129
New
9
Increased
50
Reduced
34
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mineralys Therapeutics
MLYS
|
+$10.3M |
| 2 |
TSVT
2seventy bio
TSVT
|
+$5.44M |
| 3 |
Vera Therapeutics
VERA
|
+$4.63M |
| 4 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$4.57M |
| 5 |
Treace Medical Concepts
TMCI
|
+$4.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelixis
EXEL
|
+$8.88M |
| 2 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$5.52M |
| 3 |
iRhythm Holdings
IRTC
|
+$4.01M |
| 4 |
Arrowhead Research
ARWR
|
+$3.87M |
| 5 |
HealthEquity
HQY
|
+$3.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.06% |
| 2 | Industrials | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Evolent Health
EVH
$522M
| $15.9M | 3.06% |
491,142
-94,500
| -16% | -$2.99M |
|
|
RCM
2
DELISTED
R1 RCM Inc. Common Stock
RCM
| $14.2M | 2.74% |
949,194
-403,350
| -30% | -$5.52M |
|
|
SWAV
3
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $13.6M | 2.61% |
62,550
+23,450
| +60% | +$4.57M |
|
4
UnitedHealth
UNH
$385B
| $12.3M | 2.37% |
26,075
+800
| +3% | +$386K |
|
5
BioMarin Pharmaceuticals
BMRN
$11.4B
| $12.1M | 2.33% |
124,430
-14,350
| -10% | -$1.49M |
|
|
RXDX
6
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $11.6M | 2.23% |
108,090
-4,120
| -4% | -$474K |
|
|
APLS
7
DELISTED
Apellis Pharmaceuticals
APLS
| $11.4M | 2.19% |
172,490
+20,150
| +13% | +$1.16M |
|
8
PTC Therapeutics
PTCT
$6.51B
| $11M | 2.11% |
226,566
-925
| -0.4% | -$42.3K |
|
9
Icon
ICLR
$13.1B
| $10.8M | 2.07% |
50,538
-6,112
| -11% | -$1.36M |
|
|
10
HealthEquity
HQY
$7.89B
| $10.8M | 2.07% |
183,375
-60,400
| -25% | -$3.67M |
|
11
Lantheus
LNTH
$6.75B
| $9.72M | 1.87% |
117,687
-15,000
| -11% | -$967K |
|
12
Johnson & Johnson
JNJ
$624B
| $9.63M | 1.85% |
62,100
| – | – |
|
|
13
Mineralys Therapeutics
MLYS
$2.38B
| $9.6M | 1.85% |
+613,233
| New | +$10.3M |
|
14
Option Care Health
OPCH
$3.31B
| $9.48M | 1.82% |
298,500
+25,000
| +9% | +$749K |
|
|
NARI
15
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $9.45M | 1.82% |
153,043
-27,700
| -15% | -$1.66M |
|
|
16
Treace Medical Concepts
TMCI
$263M
| $9.23M | 1.77% |
366,443
+186,519
| +104% | +$4.38M |
|
17
Insmed
INSM
$23.3B
| $8.8M | 1.69% |
516,092
| – | – |
|
18
Eli Lilly
LLY
$1.06T
| $8.16M | 1.57% |
23,765
+5,350
| +29% | +$1.8M |
|
|
AGTI
19
DELISTED
Agiliti Inc
AGTI
| $8.15M | 1.57% |
510,222
+12,000
| +2% | +$207K |
|
20
Travere Therapeutics
TVTX
$5.27B
| $8.07M | 1.55% |
358,613
+66,293
| +23% | +$1.41M |
|
21
RadNet
RDNT
$4.8B
| $7.83M | 1.51% |
312,933
+16,000
| +5% | +$348K |
|
22
Privia Health
PRVA
$3.15B
| $7.74M | 1.49% |
280,312
-41,000
| -13% | -$1.08M |
|
|
23
iRhythm Holdings
IRTC
$3.54B
| $7.33M | 1.41% |
59,136
-37,000
| -38% | -$4.01M |
|
24
Amylyx Pharmaceuticals
AMLX
$1.96B
| $7.11M | 1.37% |
242,400
+84,450
| +53% | +$2.93M |
|
25
AtriCure
ATRC
$1.67B
| $6.61M | 1.27% |
159,532
-67,000
| -30% | -$2.78M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, Sectoral Asset Management held 129 positions worth $520M, up 0.68% from $517M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Sectoral Asset Management deployed $20.7M of net new capital in Q1 2023, opening 9 new positions and adding to 50 existing holdings. Its largest new stake was Mineralys Therapeutics: 613,233 shares worth $9.6M.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 95% a quarter earlier, followed by Industrials.
On the sell side, the largest reduction was R1 RCM Inc. Common Stock, an estimated $5.52M trimmed.
- Sectoral Asset Management's largest Q1 2023 buy was Mineralys Therapeutics: 613,233 shares worth $9.6M.
- Sectoral Asset Management added most to Shockwave Medical, Inc. Common Stock in Q1 2023, an estimated $4.57M increase.
- Sectoral Asset Management's biggest Q1 2023 reduction was R1 RCM Inc. Common Stock, cutting an estimated $5.52M.
- Sectoral Asset Management fully exited Exelixis in Q1 2023, selling an estimated $8.88M.
- Sectoral Asset Management's ten largest holdings make up 24% of its $520M portfolio in Q1 2023.
- Sectoral Asset Management opened 9 new positions and closed 11 in Q1 2023.
- Sectoral Asset Management's portfolio value rose 0.68% quarter-over-quarter to $520M.
Based on Sectoral Asset Management's 13F filing for Q1 2023, filed 12 May 2023.